Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1976 Aug;14(2):416–421. doi: 10.1128/iai.14.2.416-421.1976

Interaction between Coxiella burnetii and guinea pig peritoneal macrophages.

R A Kishimoto, J S Walker
PMCID: PMC420900  PMID: 971955

Abstract

The phagocytosis and subsequent degradation of phase I and II Coxiella burnetii by macrophages obtained from immune and nonimmune guinea pigs were compared. Phase I rickettsiae were more resistant to phagocytosis than were phase II organisms. There was no significant difference in the percentage of phagocytosis of either phase of rickettsiae by macrophages from immune or nonimmune animals. After ingestion, phase I and II organisms pretreated with normal serum multiplied and destroyed normal macrophages as well as macrophages obtained from guinea pigs immunized with phase II rickettsiae. In contrast, only phase I organisms were degraded by macrophages from phase I-immunized animals in the presence of normal serum. Immune serum rendered rickettsiae more susceptible to phagocytosis and also potentiated the destruction of organisms by all types of macrophages. The specificity of macrophages from phase I animals to degrade only phase I rickettsiae was demonstrated by the ability of Rickettsia rickettsii to replicate in these macrophages.

Full text

PDF
416

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S. E., Jr, Remington J. S. Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med. 1974 May 1;139(5):1154–1174. doi: 10.1084/jem.139.5.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Avila F. R., Schultz R. M., Tompkins W. A. Specific macrophage immunity to vaccinia virus: macrophage-virus interaction. Infect Immun. 1972 Jul;6(1):9–16. doi: 10.1128/iai.6.1.9-16.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BREZINA R., KAZAR J. STUDY OF THE ANTIGENIC STRUCTURE OF COXIELLA BURNETI. IV. PHAGOCYTOSIS AND OPSONIZATION IN RELATION TO THE PHASES OF C. BURNETI. Acta Virol. 1965 May;9:268–274. [PubMed] [Google Scholar]
  4. DAVID J. R., AL-ASKARI S., LAWRENCE H. S., THOMAS L. DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS. J Immunol. 1964 Aug;93:264–273. [PubMed] [Google Scholar]
  5. Downs C. M. Phagocytosis of coxiella burneti, phase I and phase II by peritoneal monocytes from normal and immune guinea pigs and mice. Zentralbl Bakteriol Orig. 1968 Apr;206(3):329–343. [PubMed] [Google Scholar]
  6. Fowles R. E., Fajardo I. M., Leibowitch J. L., David J. R. The enhancement of macrophage bacteriostasis by products of activated lymphocytes. J Exp Med. 1973 Oct 1;138(4):952–964. doi: 10.1084/jem.138.4.952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GIMENEZ D. F. STAINING RICKETTSIAE IN YOLK-SAC CULTURES. Stain Technol. 1964 May;39:135–140. doi: 10.3109/10520296409061219. [DOI] [PubMed] [Google Scholar]
  8. Gambrill M. R., Wisseman C. L., Jr Mechanisms of immunity in typhus infections. I. Multiplication of typhus rickettsiae in human macrophage cell cultures in the nonimmune system: influence of virulence of rickettsial strains and of chloramphenicol. Infect Immun. 1973 Oct;8(4):519–527. doi: 10.1128/iai.8.4.519-527.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Greer B., Delfs D., McElree H. Electron microscope study of the interaction of vaccinia virus with macrophages from immunized and nonimmunized rabbits. Infect Immun. 1974 Feb;9(2):452–459. doi: 10.1128/iai.9.2.452-459.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Holmes B., Quie P. G., Windhorst D. B., Pollara B., Good R. A. Protection of phagocytized bacteria from the killing action of antibiotics. Nature. 1966 Jun 11;210(5041):1131–1132. doi: 10.1038/2101131a0. [DOI] [PubMed] [Google Scholar]
  11. Kazár J., Brezina R., Kovácová E., Urvölgyi J. Testing in various systems of the neutralizing capacity of Q fever immune sera. Acta Virol. 1973 Jan;17(1):79–89. [PubMed] [Google Scholar]
  12. Kazár J., Skultétyová E., Brezina R. Phagocytosis of Coxiella burneti by macrophages. Acta Virol. 1975 Sep;19(5):426–431. [PubMed] [Google Scholar]
  13. Kenyon R. H., Pedersen C. E., Jr Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization. J Clin Microbiol. 1975 Jun;1(6):500–503. doi: 10.1128/jcm.1.6.500-503.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McGregor D. D., Koster F. T. The mediator of cellular immunity. IV. Cooperation between lymphocytes and mononuclear phagocytes. Cell Immunol. 1971 Aug;2(4):317–325. doi: 10.1016/0008-8749(71)90066-9. [DOI] [PubMed] [Google Scholar]
  15. Nathan C. F., Karnovsky M. L., David J. R. Alterations of macrophage functions by mediators from lymphocytes. J Exp Med. 1971 Jun 1;133(6):1356–1376. doi: 10.1084/jem.133.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. ORMSBEE R. A., PARKER H., PICKENS E. G. The comparative effectiveness of aureomycin, terramycin, chloramphenicol erythromycin, and thiocymetin in suppressing experimental rickettsial infections in chick embryos. J Infect Dis. 1955 Mar-Apr;96(2):162–167. doi: 10.1093/infdis/96.2.162. [DOI] [PubMed] [Google Scholar]
  17. Patterson R. J., Youmans G. P. Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis. Infect Immun. 1970 Jun;1(6):600–603. doi: 10.1128/iai.1.6.600-603.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. SHAFFER J. M., KUCERA C. J., SPINK W. W. The protection of intracellular brucella against therapeutic agents and the bactericidal action of serum. J Exp Med. 1953 Jan;97(1):77–90. doi: 10.1084/jem.97.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Silberman R., Fiset P. Method for counting Rickettsiae and Chlamydiae in purified suspensions. J Bacteriol. 1968 Jan;95(1):259–261. doi: 10.1128/jb.95.1.259-261.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Simon H. B., Sheagren J. N. Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity. J Exp Med. 1971 Jun 1;133(6):1377–1389. doi: 10.1084/jem.133.6.1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tizard I. R. Macrophage-cytophilic antibodies and the functions of macrophage-bound immunoglobulins. Bacteriol Rev. 1971 Dec;35(4):365–378. doi: 10.1128/br.35.4.365-378.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tompkins W. A., Zarling J. M., Rawls W. E. In vitro assessment of cellular immunity to vaccinia virus: contribution of lymphocytes and macrophages. Infect Immun. 1970 Dec;2(6):783–790. doi: 10.1128/iai.2.6.783-790.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. WHITTICK J. W. Necropsy findings in a case of Q fever in Britain. Br Med J. 1950 Apr 29;1(4660):979–980. doi: 10.1136/bmj.1.4660.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wisseman C. L., Jr, Fiset P., Ormsbee R. A. Interaction of rickettsiae and phagocytic host cells. V. Phagocytic and opsonic interactions of phase 1 and phase 2 Coxiella burneti with normal and immune human leukocytes and antibodies. J Immunol. 1967 Oct;99(4):669–674. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES